| 1499 |
National Cancer Institute |
Html |
en |
Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of paranasal sinus and nasal cavity cancer. |
| hemiparanasal sinus | 0.501642 |
| cure rates | 0.493854 |
| positive nodes | 0.488668 |
| standard treatment schedules | 0.549584 |
| Nodal involvement | 0.497639 |
| cancer deaths | 0.490757 |
| small percentage | 0.485324 |
| paranasal sinuses | 0.76526 |
| operable tumors | 0.521562 |
| PDQ cancer information | 0.674275 |
| (es). | 0.507032 |
| T1 mucosal carcinomas | 0.579667 |
| neck radiation therapy | 0.604078 |
| cancer information summary | 0.645943 |
| frequent type | 0.494315 |
| high doses | 0.481624 |
| Squamous cell carcinoma | 0.582109 |
| breast cancer prevention | 0.543533 |
| direct extension | 0.48751 |
| malignant degeneration | 0.512598 |
| advanced carcinomas | 0.493525 |
| ethmoid sinuses | 0.558752 |
| NCI’s PDQ | 0.512104 |
| NCI PDQ cancer | 0.582736 |
| paranasal sinus cancers | 0.63814 |
|
| radical surgery | 0.487234 |
| frontal sinuses | 0.560784 |
| radiation therapy | 0.931486 |
| low-grade benign tumor | 0.581394 |
| maxillary sinus | 0.511122 |
| locoregional recurrence accounts | 0.563108 |
| nasal vestibule | 0.506572 |
| Lymph nodes | 0.492664 |
| vital areas | 0.483188 |
| distant metastases | 0.516432 |
| bony confines | 0.499241 |
| malignant tumor | 0.600994 |
| PDQ documents | 0.510902 |
| early tumors | 0.514544 |
| radical radiation therapy | 0.591316 |
| advanced disease | 0.493565 |
| nasal cavity | 0.593061 |
| treatment volume | 0.481814 |
| local disease | 0.484616 |
| tumors | 0.539577 |
| stage III tumors | 0.513203 |
| neck cancer | 0.495811 |
| postoperative radiation therapy | 0.591777 |
| adjacent structures. | 0.488857 |
|
CLICK HERE |
| 1599 |
National Cancer Institute |
Html |
en |
Selected Vegetables/Sun's Soup (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the use of selected vegetables/Sun's soup as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only. |
| General Information section | 0.439986 |
| phase I/II | 0.372901 |
| soup | 0.641588 |
| eligible patients | 0.381172 |
| United States | 0.398891 |
| Human/Clinical Studies section | 0.504014 |
| standard laboratory chow | 0.498456 |
| advanced non-small cell | 0.617549 |
| toxicity arm | 0.381025 |
| control group | 0.47167 |
| Sun’s Soup | 0.39938 |
| cell lung cancer. | 0.443882 |
| Soup treatment group. | 0.419226 |
| fed standard laboratory | 0.408383 |
| conventional therapy | 0.380328 |
| Vegetables/Sun’s Soup | 0.633353 |
| dietary supplements | 0.390642 |
| tumor growth | 0.410892 |
| percent body-weight loss | 0.372171 |
| lymph node metastasis | 0.373015 |
| average KPS score | 0.387592 |
| barbat skullcap | 0.397578 |
| cancer information summary | 0.38735 |
| patent document | 0.416332 |
|
| clinical trial | 0.401308 |
| mung bean | 0.484404 |
| barbata D. Don | 0.434127 |
| best supportive care | 0.383219 |
| shiitake mushroom | 0.46504 |
| patients | 0.656235 |
| primary tumor | 0.381698 |
| Selected Vegetables/Sun | 0.926979 |
| Scutellaria barbata D. | 0.437829 |
| KPS score | 0.444385 |
| non-small cell lung | 0.820617 |
| survival arm | 0.438189 |
| Phaseolus radiatus L. | 0.435744 |
| nonconsecutive case series | 0.385568 |
| median survival time | 0.500228 |
| cell lung cancer | 0.65934 |
| study entry | 0.475867 |
| Soup treatment group | 0.54526 |
| radiation therapy | 0.522928 |
| Hedyotis diffusa Willd. | 0.437904 |
| mice fed standard | 0.407302 |
| Soup dietary supplement | 0.400111 |
| I/II clinical trial | 0.398282 |
|
CLICK HERE |
| 1617 |
National Cancer Institute |
Html |
en |
Chronic Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of chronic myeloproliferative neoplasms. |
| red blood cells | 0.746761 |
| chronic idiopathic myelofibrosis | 0.40092 |
| cancer treatment | 0.416363 |
| primary myelofibrosis | 0.53957 |
| PDQ cancer information | 0.430215 |
| bone marrow aspiration | 0.385705 |
| clinical trial search | 0.421224 |
| white blood cells | 0.676519 |
| chronic eosinophilic leukemia | 0.451961 |
| blood cells increases | 0.444984 |
| clinical trials | 0.768861 |
| chronic neutrophilic leukemia | 0.40279 |
| mature blood cells | 0.434847 |
| fewer blood cells | 0.406923 |
| cancer information summary | 0.401424 |
| clinical trial | 0.500574 |
| early signs | 0.377313 |
| patients | 0.431687 |
| blood cells | 0.902472 |
| blood vessels | 0.37721 |
| chronic myelogenous leukemia | 0.406738 |
| Treatment Editorial Board | 0.377482 |
| essential thrombocythemia | 0.420345 |
| treatment | 0.55278 |
| stored stem cells | 0.37624 |
|
| immature blood cells | 0.399031 |
| blood stem cell | 0.37725 |
| cancer cells | 0.408902 |
| -fighting blood cells | 0.405086 |
| lymphoid stem cell | 0.374191 |
| specific cancer cells | 0.392312 |
| chronic myeloproliferative neoplasms | 0.69658 |
| signs | 0.38226 |
| polycythemia vera | 0.418683 |
| patient | 0.388228 |
| treatment clinical trials | 0.396123 |
| blood stem cells | 0.497004 |
| National Cancer Institute | 0.457233 |
| routine blood test | 0.45249 |
| new treatment | 0.393316 |
| white blood cell | 0.399685 |
| extra blood cells | 0.469808 |
| bone marrow | 0.605562 |
| PDQ summary | 0.382577 |
| cancer clinical trials | 0.425229 |
| blood clots | 0.392843 |
| cancer | 0.517448 |
| information | 0.439199 |
| Myelogenous Leukemia Treatment | 0.387746 |
|
CLICK HERE |
| 1625 |
National Cancer Institute |
Html |
en |
Vulvar Cancer Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of vulvar cancer. |
| clinical trial | 0.306795 |
| treatment | 0.33468 |
| vulvar cancer | 0.816472 |
| lymph node biopsy | 0.279435 |
| vulvar intraepithelial neoplasia | 0.273676 |
| sentinel lymph node | 0.432305 |
| cancer cells | 0.248189 |
| Recurrent vulvar cancer | 0.242509 |
|
| PDQ cancer information | 0.200769 |
| Radical local excision | 0.22415 |
| cancer clinical trials | 0.214832 |
| lymph nodes | 0.572468 |
| radiation therapy | 0.379761 |
| National Cancer Institute | 0.219981 |
| cancer | 0.970335 |
| clinical trials | 0.629959 |
|
CLICK HERE |
| 1637 |
National Cancer Institute |
Html |
en |
Coenzyme Q10 (PDQ®)–Patient Version |
Coenzyme Q10 is naturally made by the body and can be taken as a pill or injection. Studies have shown it to help protect the heart from damaging side effects of doxorubicin and to stimulate the immune system in cancer patients. Read about the results of clinical trials in cancer patients using coenzyme Q10 in this expert-reviewed summary. |
| cancer treatment | 0.549646 |
| body | 0.488461 |
| PDQ cancer information | 0.604928 |
| Cancer Complementary | 0.504149 |
| clinical trials | 0.78289 |
| CoQ10 supplements | 0.61864 |
| health care providers | 0.511973 |
| mg CoQ10 | 0.629362 |
| cancer information summary | 0.559761 |
| alternative cancer therapies | 0.503732 |
| clinical trial | 0.520374 |
| CAM cancer research | 0.490752 |
| free radicals | 0.529211 |
| therapies | 0.527068 |
| conventional cancer therapies | 0.505246 |
| breast cancer patients | 0.577878 |
| patients | 0.653188 |
| cancer patients | 0.613167 |
| adjuvant therapy | 0.48477 |
| CoQ10 therapy | 0.668716 |
| NCI PDQ cancer | 0.520611 |
| cancer information database | 0.499763 |
| CoQ10 analogs | 0.637275 |
| Therapies Editorial Board | 0.506627 |
|
| cancer information | 0.615008 |
| treatment | 0.639358 |
| cancer prevention | 0.483763 |
| Complementary Therapies Editorial | 0.521183 |
| CoQ10 | 0.914047 |
| Drug Administration | 0.508672 |
| Cancer Information Specialist | 0.495609 |
| cancer cells | 0.510132 |
| Cancer Information Service | 0.558797 |
| treatment clinical trials | 0.486207 |
| National Cancer Institute | 0.655789 |
| studies | 0.570221 |
| alternative medicine | 0.536733 |
| health care | 0.547179 |
| scientific journals | 0.497807 |
| Federal Trade Commission | 0.485869 |
| new treatment | 0.531574 |
| Cancer Care page | 0.483491 |
| breast cancer | 0.62622 |
| animal studies | 0.506664 |
| cancer clinical trials | 0.505899 |
| alternative therapies | 0.521758 |
| cancer information summaries | 0.500194 |
| cancer | 0.924813 |
|
CLICK HERE |
| 2027 |
National Cancer Institute |
Html |
es |
Prevención del cáncer colorrectal (PDQ®)–Versión para pacientes |
Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer colorrectal y sobre las investigaciones dirigidas a prevenir esta enfermedad. |
| Problemas renales | 0.523957 |
| siguientes factores | 0.953317 |
| voluntarios sanos | 0.523051 |
| Physician Data Query | 0.604817 |
| siguientes afecciones | 0.551171 |
| Estados Unidos | 0.609005 |
| posibles daños | 0.574254 |
| cuerpo).ampliar anatomÃa | 0.537676 |
| suficiente ejercicio | 0.534096 |
| prevención revisa | 0.526315 |
|
| menor riesgo | 0.62051 |
| PDQ Prevención | 0.545917 |
| Antecedentes familiares | 0.532247 |
| National Cancer Institute | 0.526671 |
| tumores benignos | 0.586261 |
| siguientes riesgos | 0.524072 |
| siguientes sumarios | 0.58101 |
| alto contenido | 0.561192 |
| Instituto Nacional | 0.54913 |
|
CLICK HERE |
| 3440 |
National Cancer Institute |
Html |
es |
Exámenes de detección del neuroblastoma (PDQ®)–Versión para pacientes |
Sumario de información revisada por expertos sobre pruebas que se usan para detectar el neuroblastoma. |
| Visuals Online | 0.563675 |
| PDQ Exámenes | 0.77452 |
| Physician Data Query | 0.971175 |
| ecografÃa fetal | 0.642315 |
| prevención revisa | 0.581226 |
| graves riesgos | 0.622769 |
|
| presente sÃntomas | 0.605798 |
| información ayuda | 0.590632 |
| cuáles tipos | 0.60865 |
| National Cancer Institute | 0.613572 |
| siguientes riesgos | 0.582879 |
| Instituto Nacional | 0.71673 |
|
CLICK HERE |
| 3515 |
National Cancer Institute |
Html |
en |
Types of Clinical Trials |
Information about the several types of cancer clinical trials, including treatment trials, prevention trials, screening trials, supportive and palliative care trials. Each type of trial is designed to answer different research questions. |
| agent studies | 0.634708 |
| large number | 0.487416 |
| treatment studies | 0.534627 |
| unnecessary follow-up tests | 0.564207 |
| standard treatments | 0.500667 |
| palliative care trials | 0.620026 |
| nutrition problems | 0.486132 |
| approach prevent cancer | 0.592087 |
| specific changes | 0.499234 |
| researchers | 0.486118 |
| cancer patients | 0.507417 |
| treatment trials | 0.63562 |
| Cancer prevention trials | 0.614093 |
| healthy people | 0.501177 |
| cancer screening trials | 0.613302 |
| chemoprevention studies | 0.50869 |
| health problems | 0.485883 |
| high risk | 0.560244 |
| radiation therapy | 0.500589 |
| new ways | 0.649746 |
| safe dose | 0.499447 |
| life | 0.456389 |
| answers questions | 0.498733 |
| action studies | 0.564584 |
| dietary supplements | 0.491505 |
|
| studies | 0.663766 |
| newer treatment trials | 0.614927 |
| certain medicines | 0.490022 |
| different research questions | 0.599262 |
| new treatment | 0.895243 |
| sleep disorders | 0.486249 |
| disease | 0.456977 |
| effective screening test | 0.579302 |
| certain type | 0.487292 |
| support groups | 0.492526 |
| people | 0.64215 |
| better quality | 0.492262 |
| genetic changes | 0.499368 |
| new treatment help | 0.724782 |
| tumors | 0.439813 |
| cancer clinical trials | 0.74573 |
| new places | 0.514069 |
| trials | 0.781895 |
| treatment help people | 0.60481 |
| cancer risk | 0.517947 |
| cancer | 0.948957 |
| prevention trials | 0.744319 |
| new cancer | 0.533494 |
| test new treatments | 0.617153 |
|
CLICK HERE |
| 3650 |
National Cancer Institute |
Html |
en |
CRISPR: Genome Editing Comes of Age |
A research article about a technique for gene editing known as CRISPR-Cas9. The technique has made it much easier and faster for cancer researchers to study mutations and test new therapeutic targets. |
| next-generation DNA sequencing | 0.3795 |
| new targets | 0.314335 |
| activator-like effector nucleases | 0.397418 |
| potentially druggable genes | 0.453893 |
| future combination therapy | 0.360962 |
| cancer therapy | 0.352224 |
| unique gene | 0.31507 |
| cancer growth | 0.426678 |
| abnormal regulatory networks | 0.387625 |
| cancer cell line | 0.572636 |
| short palindromic repeats | 0.389333 |
| genome editing | 0.387426 |
| new therapeutic targets | 0.398394 |
| genes | 0.545435 |
| cell division | 0.314215 |
| Cancer phenotypes | 0.335586 |
| human cell | 0.318044 |
| target genes | 0.365123 |
| lymphoma cells | 0.394771 |
| cancer drug targets | 0.463263 |
| drug resistant tumors | 0.385077 |
| David Baltimore | 0.313639 |
| Ji Luo | 0.374003 |
| drug resistance | 0.449373 |
|
| DNA sequencing | 0.398873 |
| potential combination therapies | 0.357658 |
| possible therapeutic approaches | 0.357025 |
| gene targets | 0.319574 |
| gene expression—it | 0.322364 |
| drug resistance question | 0.384228 |
| CRISPR libraries | 0.319128 |
| cancer cells | 0.810099 |
| cancer cell lines | 0.446525 |
| Dr. Luo | 0.937997 |
| Dr. Staudt | 0.543567 |
| CRISPR method | 0.325677 |
| CRISPR technology | 0.334008 |
| Hannover Medical School | 0.387381 |
| Cancer Research | 0.352397 |
| normal cells | 0.431696 |
| cancer researchers | 0.367853 |
| CRISPR | 0.510355 |
| cell death | 0.314175 |
| transformative technology | 0.318261 |
| technology | 0.365907 |
| Cancer Genome Atlas | 0.450206 |
| gene editing | 0.330972 |
| genetic changes | 0.316809 |
|
CLICK HERE |
| 4383 |
National Cancer Institute |
Html |
en |
Anyone Can Get Skin Cancer |
No matter if your skin is light, dark, or somewhere in between, everyone is at risk for skin cancer. Learn what skin cancer looks like, how to find it early, and how to lower the chance of skin cancer. |
| skin cancer | 0.964567 |
| UV rays | 0.456636 |
| dark band | 0.53853 |
| new mole | 0.452556 |
| dark patch | 0.449539 |
| body | 0.421991 |
| waxy bump | 0.459872 |
| Wear sunglasses | 0.448376 |
| ) bump. | 0.459875 |
| talk | 0.420942 |
| common sign | 0.451092 |
| skin light | 0.47582 |
| different types | 0.451536 |
| jagged scar | 0.458002 |
| exposure | 0.417645 |
| medical conditions | 0.448166 |
| sore | 0.426359 |
| UVB rays | 0.455332 |
| broad spectrum | 0.449203 |
| women | 0.411421 |
| UVA | 0.425118 |
| sunscreen | 0.411184 |
| high level | 0.447722 |
| dark skin | 0.502452 |
| changes | 0.445228 |
|
| skin conditions | 0.464403 |
| cancer cells | 0.45646 |
| cell skin cancer | 0.522134 |
| firm red lump | 0.495754 |
| sun | 0.50802 |
| skin tone | 0.480812 |
| eyes | 0.41674 |
| old growth | 0.501248 |
| different color | 0.450303 |
| men | 0.411424 |
| certain medicines | 0.448412 |
| advanced skin cancers | 0.508812 |
| younger children | 0.460432 |
| change | 0.452939 |
| long sleeves | 0.44884 |
| No. | 0.411646 |
| skin ulcers | 0.466159 |
| people | 0.446457 |
| doctor | 0.48532 |
| sunlight | 0.422273 |
| cause damage | 0.452334 |
| new growth | 0.497988 |
| risk | 0.471314 |
| low level | 0.448421 |
|
CLICK HERE |